ArticleBMC cancer2008

COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ.

Swati Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.